Trial Profile
A Retrospective study to compare the efficacy of oral Capecitabine versus intravenous 5‐FU in patients undergoing neoadjuvant CRT for Rectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 04 Dec 2018 New trial record